MapLight Therapeutics, Inc. Common Stock (MPLT) — Long-term Investment Intensity
MapLight Therapeutics, Inc. Common Stock (MPLT) has a Long-term Investment Intensity of 30.9% as of December 2025. Long-term investments of $147.99 Million represent 30.9% of total assets of $479.51 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore MapLight Therapeutics, Inc. Common Stock cash conversion from operations to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
MapLight Therapeutics, Inc. Common Stock Long-term Investment Intensity (2025–2025)
This chart shows how MapLight Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of December 2025, the intensity stands at 30.9%, reflecting long-term investments of $147.99 Million against total assets of $479.51 Million USD. Explore MPLT operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for MapLight Therapeutics, Inc. Common Stock (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for MapLight Therapeutics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see MapLight Therapeutics, Inc. Common Stock stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 30.9% | $147.99 Million | $479.51 Million | — |